Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies
- PMID: 1585257
- DOI: 10.1002/syn.890100209
Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies
Abstract
The present document is the final of three parts of a review that focuses on recent data from clinical and animal research concerning the biochemical bases of depressive disorders, diagnosis, and treatment. Various treatments for depression, including psychotherapy, pharmacological, and somatic treatments, will be described in this third part. Also, some of the controversies in the field, as well as a summary of the most salient points of the review, will be discussed. Previous sections of this review dealt with the classification of depressive disorders and research techniques for studying the biochemical mechanisms of these disorders (Part I) and various transmitter/receptor theories of depressive disorder (Part II).
Similar articles
-
Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories.Synapse. 1991 Dec;9(4):251-301. doi: 10.1002/syn.890090404. Synapse. 1991. PMID: 1685032 Review.
-
Clinical and biochemical aspects of depressive disorders: I. Introduction, classification, and research techniques.Synapse. 1991 Jul;8(3):185-211. doi: 10.1002/syn.890080306. Synapse. 1991. PMID: 1948669 Review.
-
Innovative somatic treatments for depression.Psychiatr Med. 1991;9(1):77-103. Psychiatr Med. 1991. PMID: 2017569 Review.
-
[Prolactin, depression and antidepressive agents. Review of the literature].Encephale. 1987 May-Jun;13(3):101-12. Encephale. 1987. PMID: 3297633 Review. French.
-
Depression: a review of acute pharmacological treatment.Psychiatr J Univ Ott. 1989 Jun;14(2):372-4; discussion 379-80. Psychiatr J Univ Ott. 1989. PMID: 2668992 Review.
Cited by
-
Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.Psychopharmacology (Berl). 2007 Jun;192(3):357-71. doi: 10.1007/s00213-007-0728-9. Epub 2007 Feb 21. Psychopharmacology (Berl). 2007. PMID: 17318507
-
The role of serotonin receptor subtypes in treating depression: a review of animal studies.Psychopharmacology (Berl). 2011 Feb;213(2-3):265-87. doi: 10.1007/s00213-010-2097-z. Epub 2010 Nov 24. Psychopharmacology (Berl). 2011. PMID: 21107537 Free PMC article. Review.
-
Brain monoamine oxidase A inhibition in cigarette smokers.Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14065-9. doi: 10.1073/pnas.93.24.14065. Proc Natl Acad Sci U S A. 1996. PMID: 8943061 Free PMC article.
-
Brain monoamine oxidase A activity predicts trait aggression.J Neurosci. 2008 May 7;28(19):5099-104. doi: 10.1523/JNEUROSCI.0925-08.2008. J Neurosci. 2008. PMID: 18463263 Free PMC article.
-
Low monoamine oxidase B in peripheral organs in smokers.Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11600-5. doi: 10.1073/pnas.1833106100. Epub 2003 Sep 12. Proc Natl Acad Sci U S A. 2003. PMID: 12972641 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical